title: Establishing and using a community inter-agency client monitoring system to develop addictions treatment programs.
abstract: The Substance Abuse Monitor is a comprehensive community-based addictions information system that forms the basis for an innovative approach to community needs assessment. This paper describes: (1) the conditions that created the need and support for the monitoring system; (2) the community development strategy that was employed to secure the commitment of agencies to the project; (3) the specifics of the needs assessment procedures; (4) some of the theoretical, clinical and methodological issues on which the procedures are based; (5) the practical applications of the system; and (6) the limitations of the system. The establishment of the database was based upon the idea that there would be benefits at several levels: the community, the participating agencies, the individual counsellors and the clients. The realization of these benefits requires that the information collected and the results generated must be capable of addressing specific service delivery problems with practical and tangible solutions. It is argued that the project has been successful in generating such solutions, and has considerable potential as an ongoing needs assessment tool.
authors.affiliation: Addiction Research Foundation, Hamilton, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: DeVillaer
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000453:epidemiology / Q000534:rehabilitation*; D019058:Community Networks / Q000706:statistics & numerical data*; D003625:Data Collection; D005260:Female; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data*; D006801:Humans; D013287:Illicit Drugs; D007256:Information Systems; D008297:Male; D008498:Medical Record Linkage; D009864:Ontario; D010043:Outcome and Process Assessment, Health Care; D011619:Psychotropic Drugs; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs